This Article  • References  • Full text PDF  • Reply to article  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citation map  • Citing articles on HighWire  • Contact me when this article is cited  Related Content  • Similar articles in this journal  Social Bookmarking   What's this?

Report of the Veterans Administration and National Institute of Mental Health Collaborative Study Group

Robert F. Prien, PhD; Perry Point, Md; Eugene M. Caffey, Jr, MD; C. James Klett, PhD; Perry Point, Md

Arch Gen Psychiatry. 1973;28(3):337-341.

Abstract
In an 18 hospital study, 205 patients hospitalized with a diagnosis of manic-depressive illness, manic type, were treated upon discharge with lithium carbonate or placebo for a two-year period. Lithium carbonate was significantly more effective than placebo in preventing relapses (ie, affective episodes severe enough to require hospitalization or use of nonstudy drugs). The difference in treatment outcome between lithium carbonate and placebo was due mainly to the lower incidence of manic relapses on lithium carbonate. Patients on lithium carbonate also had a lower incidence of depressive relapses than patients on placebo but the limited incidence of severe depression in this sample makes it difficult to draw any conclusions regarding the prophylactic efficacy of lithium carbonate in depressive illness. The results from this trial coupled with those from other studies indicate that lithium carbonate combined with regular clinical appraisals is a safe and effective treatment for preventing relapse in manic-depressive illness.

Author Affiliations
Washington, DC

From the Central Neuropsychiatric Research Laboratory, Veterans Administration Hospital, Perry Point, Md (Drs. Prien and Klett), and the Mental Health and Behavioral Sciences Service, Department of Medicine and Surgery, Veterans Administration, Washington, DC (Dr. Caffey).

Footnotes
Accepted for publication Dec 4, 1972.

Reprint requests to Central NP Research Laboratory, VA Hospital, Perry Point, Md 21902 (Dr. Prien).

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

The use of anticonvulsants in the aftermath of mania
Cookson and Elliott
J Psychopharmacol 2006;20:23-30.
ABSTRACT  

Bipolar Disorder Treatment: An Evidence-Based Reality Check
DePaulo
Am. J. Psychiatry 2006;163:175-176.
FULL TEXT  

Lithium in the Prevention of Suicidal Behavior and All-Cause Mortality in Patients With Mood Disorders: A Systematic Review of Randomized Trials
Cipriani et al.
Am. J. Psychiatry 2005;162:1805-1819.
ABSTRACT | FULL TEXT  

Olanzapine Versus Lithium in the Maintenance Treatment of Bipolar Disorder: A 12-Month, Randomized, Double-Blind, Controlled Clinical Trial
Tohen et al.
Am. J. Psychiatry 2005;162:1281-1290.
ABSTRACT | FULL TEXT  

Advancing the pharmacological treatment of bipolar depression
Frangou
Adv. Psychiatr. Treat. 2005;11:28-37.
ABSTRACT | FULL TEXT  

Long-Term Lithium Therapy for Bipolar Disorder: Systematic Review and Meta-Analysis of Randomized Controlled Trials
Geddes et al.
Am. J. Psychiatry 2004;161:217-222.
ABSTRACT | FULL TEXT  

What Is a "Mood Stabilizer"? An Evidence-Based Response
Bauer and Mitchner
Am. J. Psychiatry 2004;161:3-18.
ABSTRACT | FULL TEXT  

Suicide Risk in Bipolar Disorder During Treatment With Lithium and Divalproex
Goodwin et al.
JAMA 2003;290:1467-1473.
ABSTRACT | FULL TEXT  

Relapse Prevention and Bipolar Disorder: A Focus on Bipolar Depression
Rapaport and Hales
Focus 2003;1:15-31.
ABSTRACT | FULL TEXT  

Practice Guideline for the Treatment of Patients With Bipolar Disorder (Revision)
Hirschfeld et al.
Focus 2003;1:64-110.
FULL TEXT  

Effect of Abrupt Change From Standard to Low Serum Levels of Lithium: A Reanalysis of Double-Blind Lithium Maintenance Data
Perlis et al.
Am. J. Psychiatry 2002;159:1155-1159.
ABSTRACT | FULL TEXT  

National Depressive and Manic-Depressive Association Consensus Statement on the Use of Placebo in Clinical Trials of Mood Disorders
Charney et al.
Arch Gen Psychiatry 2002;59:262-270.
ABSTRACT | FULL TEXT  

Evolving methodologies in bipolar disorder maintenance research
CALABRESE et al.
Br. J. Psychiatry 2001;178 :s157-s163.
ABSTRACT | FULL TEXT  

Precursors of compliance with lithium treatment in affective disorders
McCleod and Sharp
Psychiatr. Bull. 2001;25:183-186.
ABSTRACT | FULL TEXT  

A Randomized, Placebo-Controlled 12-Month Trial of Divalproex and Lithium in Treatment of Outpatients With Bipolar I Disorder
Bowden et al.
Arch Gen Psychiatry 2000;57:481-489.
ABSTRACT | FULL TEXT  

Long-Term Outcome of Lithium Prophylaxis in Bipolar Disorder: A 5-Year Prospective Study of 402 Patients at a Lithium Clinic
Maj et al.
Am. J. Psychiatry 1998;155:30-35.
ABSTRACT | FULL TEXT  

Forty Years of Lithium Treatment
Moncrieff et al.
Arch Gen Psychiatry 1998;55:92-93.
FULL TEXT  

Current Therapeutic Profile of Lithium
Gershon and Soares
Arch Gen Psychiatry 1997;54:16-20.
ABSTRACT  

Pharmacologic Treatment of Bipolar Disorder Through the Life Cycle
Jackson
Journal of Pharmacy Practice 1996;9:95-103.
ABSTRACT  

Subsyndromal Symptoms in Bipolar Disorder: A Comparison of Standard and Low Serum Levels of Lithium
Keller et al.
Arch Gen Psychiatry 1992;49:371-376.
ABSTRACT  

The management of treatment-resistant affective disorder: clinical perspectives
Malizia and Bridges
J Psychopharmacol 1992;6:145-155.
 

Risk of Recurrence Following Discontinuation of Lithium Treatment in Bipolar Disorder
Suppes et al.
Arch Gen Psychiatry 1991;48:1082-1088.
ABSTRACT  

Outcome in Manic Disorders: A Naturalistic Follow-up Study
Harrow et al.
Arch Gen Psychiatry 1990;47:665-671.
ABSTRACT  

Risk Factors for Suicide in Psychiatric Patients
Roy
Arch Gen Psychiatry 1982;39:1089-1095.
ABSTRACT  

Psychiatric Morbidity From Long-term Medications
DePaulo
JAMA 1982;247:1867-1867.
ABSTRACT  

Prophylactic Lithium Carbonate With and Without Imipramine for Bipolar 1 Patients: A Double-blind Study
Quitkin et al.
Arch Gen Psychiatry 1981;38:902-907.
ABSTRACT  

Lithium in the Prophylactic Treatment of Affective Disorders
Prien
Arch Gen Psychiatry 1979;36:847-848.
ABSTRACT  

Lithium as a Prophylactic Agent in Unipolar Affective Illness: Comparison With Cyclic Antidepressants
Schou
Arch Gen Psychiatry 1979;36:849-851.
ABSTRACT  

Diagnosis in Schizophrenia and Manic-Depressive Illness: A Reassessment of the Specificity of 'Schizophrenic' Symptoms in the Light of Current Research
Pope and Lipinski
Arch Gen Psychiatry 1978;35:811-828.
ABSTRACT  

Schizo-affective Psychosis: Fact or Fiction? A Survey of the Literature
Procci
Arch Gen Psychiatry 1976;33:1167-1178.
ABSTRACT  

Prophylaxis of Affective Disorders: Current Status of Knowledge
Quitkin et al.
Arch Gen Psychiatry 1976;33:337-341.
ABSTRACT  

Lithium Carbonate and Affective Disorders: V: A Double-Blind Study of Prophylaxis of Depression in Bipolar Illness
Dunner et al.
Arch Gen Psychiatry 1976;33:117-120.
ABSTRACT  

Amitriptyline-Perphenazine Interaction in Ambulatory Schizophrenic Patients: A Controlled Study of Drug Interaction
Chouinard et al.
Arch Gen Psychiatry 1975;32:1295-1307.
ABSTRACT  

Factors Associated With Treatment Success in Lithium Carbonate Prophylaxis: Report of the Veterans Administration and National Institute of Mental Health Collaborative Study Group
Prien et al.
Arch Gen Psychiatry 1974;31:189-192.
ABSTRACT  

Clinical Factors in Lithium Carbonate Prophylaxis Failure
Dunner and Fieve
Arch Gen Psychiatry 1974;30:229-233.
ABSTRACT  

Lithium Carbonate and Imipramine in Prevention of Affective Episodes: A Comparison in Recurrent Affective Illness
Report of the Veterans Administration and National et al.
Arch Gen Psychiatry 1973;29:420-425.
ABSTRACT